Patents by Inventor Alvin L. Melliere

Alvin L. Melliere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ractopamine and growth hormone combinations
    Patent number: 5686413
    Abstract: Combined administration of a growth hormone related substance and ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine provides improved growth feed efficiency, and carcass quality. Administration of ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine that also receive growth hormone related substance reduces greater than normal blood sugar and insulin levels.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 11, 1997
    Assignee: Eli Lilly and Company
    Inventors: David B. Anderson, D. Jay Jones, Alvin L. Melliere
  • Ractopamine and growth hormone combinations
    Patent number: 5453418
    Abstract: Combined administration of a growth hormone related substance and ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine provides improved growth feed efficiency, and carcass quality. Administration of ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine that also receive growth hormone related substance reduces greater than normal blood sugar and insulin levels.This application is a continuation of application Ser. No. 07/694,628, filed May 2, 1991, now abandoned, which is a continuation-in-part of application Ser. No. 07/164,675, filed Mar. 7, 1988, now abandoned.
    Type: Grant
    Filed: November 20, 1992
    Date of Patent: September 26, 1995
    Assignee: Eli Lilly and Company
    Inventors: David B. Anderson, D. Jay Jones, Alvin L. Melliere